View Cart (0 items)

Pharmaceutical

Indian drug maker faces court action over alleged patent infringement

No Comments
Indian pharmaceutical research company Aurobindo Pharma is facing legal action from three large international competitors that have accused the company of patent infringement.
Read More

EC: Pharmaceutical industry should focus on working with member states

No Comments
Europe's pharmaceutical industry should do more to convince member states of the industry's strengths, instead of trying to change the European Commission's regulatory policy.
Read More

EU, US health officials team up to fight antimicrobial resistance

No Comments
Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

No Comments
U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

New FDA import ban hits Indian drug-making industry

No Comments
The FDA's campaign against substandard pharmaceutical products manufactured in India is continuing with a new import ban, this time imposed on drugs produced at a Bangalore facility owned and operated by Canadian company Apotex Inc.
Read More

FDA bans import of drugs from Sun Pharma's Gujarat facility

No Comments
The U.S. FDA has issued an import alert for Indian drug maker Sun Pharmaceuticals Ltd., banning the import of drug products manufactured at the company's facility in Gujarat.
Read More

Indian pharmaceutical firms braced for effect from US drug supply market mergers

No Comments
The U.S. pharmaceutical supply chain is predicted to go through a stage of consolidation which will have an impact on the Indian drug manufacturing market, according to industry experts.
Read More

US, Indian officials meet to discuss drug safety

No Comments
India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

No Comments
The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

No Comments
The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More